Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Antifungal analog offers reduced toxicity

Improved version of amphotericin B is now in clinical trial, but debate continues about its mechanism of action

by Mark Peplow, special to C&EN
November 9, 2023

Article:

This article has been sent to the following recipient: